Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,290 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07171983RecruitingPhase 1
Testing a new drug for rheumatoid arthritis
This trial tests a new medication (BMS-986454) for people with rheumatoid arthritis who haven't responded well enough to methotrexate. It aims to see if the drug is safe and how it works in the body.
Hyderabad, Andhra PradeshAges 18–65 - NCT07169695RecruitingPhase 2
Comparing a new eye drop to cyclosporine for eye allergy in kids
This study tests a new eye drop (T1695) against cyclosporine for children with moderate to severe vernal keratoconjunctivitis, a type of eye allergy. It aims to see which treatment works better and is safer for reducing symptoms.
Kolkata, West BengalAges 4–17 - NCT07166601RecruitingPhase 1
Study of a drug for advanced solid tumors with MUC-1 marker
This trial tests a new drug, M0324, alone or combined with pembrolizumab or chemotherapy, for advanced solid tumors that have a protein called MUC-1 on their surface. It may be an option for patients whose cancer has not responded to standard treatments.
New Haven, ConnecticutAges 18 years+ - NCT07168915RecruitingPhase 1
Safety study of an experimental vaccine in healthy adults
This early-phase study tests whether a new vaccine called V118E is safe and well-tolerated in healthy people. It is for adults who are in good health and have not recently had a pneumococcal infection.
Hallandale, FloridaAges 18–49 - NCT07174310RecruitingPhase 3
Prasinezumab for early Parkinson's disease
This study tests a new medication called prasinezumab, given through a vein (IV), to see if it can slow the progression of early-stage Parkinson's disease. It is for people who are on only one Parkinson's medication and have not yet developed motor complications.
Birmingham, AlabamaAges 50–85 - NCT07172919RecruitingPhase 2
Continued treatment with sotorasib for KRAS G12C cancer
This study is for people who are already taking the targeted therapy sotorasib (with or without another drug called panitumumab) in an Amgen clinical trial and are still doing well. It lets you keep receiving the same treatment after your original study ends, so you don't have to stop a medicine that is working for you.
Fort Myers, FloridaAges 18 years+ - NCT07165002RecruitingPhase 1
Study of LY3537031 in people with and without liver problems
This trial tests how a new medicine, LY3537031, moves through the body and how safe it is for people with different levels of liver function. It includes people with normal livers and those with mild, moderate, or severe liver impairment.
KistarcsaAges 18–85 - NCT07166094RecruitingPhase 3
Rina-S vs standard therapy for advanced endometrial cancer
This trial tests a new drug called Rina-S (an antibody-drug conjugate) against standard treatments for advanced endometrial cancer that has returned after prior therapy. It may be an option if you have had at least 1 but no more than 3 prior treatments, including platinum chemo and immunotherapy.
Mobile, AlabamaAges 18 years+ - NCT07166471Recruiting
Healthy reference ranges for body MRI in Singapore
This study aims to establish normal ranges for MRI measurements of the body in healthy adults. By participating, you'll help create reference standards that doctors can use to better diagnose and monitor conditions like liver and heart disease.
SingaporeAges 18 years+ - NCT07174336RecruitingPhase 3
Testing Tersolisib with other treatments for advanced breast cancer
This trial tests a new study drug called Tersolisib combined with other anti-cancer treatments for people with advanced breast cancer that has a specific gene change (PIK3CA). The goal is to see if the combination can help shrink or slow the cancer.
Anchorage, AlaskaAges 18 years+ - NCT07168759Enrolling by invitation
VR game to teach kids hygiene at school
This trial tests a virtual reality game to help children ages 6 to 12 learn and practice better hygiene habits. It compares the VR game to regular health lessons to see which is more effective.
Hong KongAges 6–12 - NCT07167056Recruiting
AI chatbot to improve quality of life in cancer patients
This trial tests whether an AI-powered chatbot can help people with cancer feel better emotionally and improve their quality of life. You can join if you are currently in cancer treatment, feeling distressed, and have a smartphone.
Weston, FloridaAges 18 years+ - NCT07171736Recruiting
Virtual reality therapy for student mental health
This trial tests if virtual reality can help students with strong inner critics or emotional pain. You'll try a therapy called schema therapy using VR to change negative thought patterns.
Groningen, Provincie GroningenAges 16 years+ - NCT07170202Recruiting
Mindfulness for young heavy drinkers
This study tests if learning mindfulness can help young adults who drink heavily cut back on alcohol. You'll practice short, easy mindfulness exercises.
Tallahassee, FloridaAges 18–29 - NCT07159555Recruiting
Neurofilament levels in late preterm newborns
This study looks at a substance in the blood called neurofilaments, which may help doctors understand early brain development in babies born a few weeks early. If your baby already needs a blood test, researchers will use a small extra sample to learn more.
LiègeAges Up to 3 weeks - NCT07162493Recruiting
Feasibility trial of ATTACH program for families in Denmark
This trial tests a program called ATTACH to help parents and young children who are facing tough challenges, like mental health problems, substance abuse, or having a child in foster care. If you are a parent with a child under 5.7 years, speak English or Danish, and are getting support from a family treatment center, you may be able to join.
GribskovAges 18 years+ - NCT07161271Recruiting
Study on a low-flow CO2 removal device for breathing failure
This study looks back at medical records of people who used a special device (ECCO2R) in the ICU to help remove carbon dioxide from the blood. The goal is to see if the device is safe and works well for patients with breathing problems.
Hong KongAges 18 years+ - NCT07160881Enrolling by invitation
Study of a CPR pillow for adults
This study tests a special pillow designed to help with CPR (cardiopulmonary resuscitation, the lifesaving chest compressions used when someone's heart stops). It looks at whether the pillow makes CPR more effective for adults who are trained to use it.
IstanbulAges 18 years+ - NCT07161518Enrolling by invitationPhase 4
Testing focused ultrasound on the brain during sedation
This trial uses focused ultrasound to gently stimulate parts of the brain while you are under sedation. It aims to understand how this technology affects brain activity and could lead to new ways to treat brain disorders without surgery.
Palo Alto, CaliforniaAges 18–65 - NCT07156578Enrolling by invitationPhase 2
Long-term bivamelagon for hypothalamic obesity
This long-term study tests a new drug, bivamelagon, for people with hypothalamic obesity. It's for those who already completed a similar study and tolerated the drug well.
Aurora, ColoradoAges 12 years+ - NCT07164313RecruitingPhase 1
ZW251 for advanced solid tumors
This trial is testing a new drug called ZW251 for people with advanced liver cancer (hepatocellular carcinoma), non-small cell lung cancer, or germ cell tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
San Francisco, CaliforniaAges 18 years+ - NCT07155226RecruitingPhase 1/Phase 2
Study of AZD3632 for advanced blood cancers with certain gene changes
This trial is testing a new drug, AZD3632, either alone or with other cancer treatments, for people with advanced blood cancers that have specific genetic changes (like KMT2Ar, NPM1m, or others that cause HOX over-expression). The goal is to see if it can help when standard treatments have stopped working.
Decatur, IllinoisAges 16 years+ - NCT07160608RecruitingPhase 2
Study of Tarperprumig for ANCA-associated vasculitis
This trial tests a new drug (tarperprumig) for people with active ANCA-associated vasculitis (GPA or MPA). The goal is to see if it is safe and effective for treating the disease, especially when standard treatments like rituximab or cyclophosphamide are being considered.
Ciudad de Buenos AiresAges 18–80 - NCT07160205RecruitingPhase 2/Phase 3
Study of ULSC for dermatomyositis and polymyositis
This trial tests a new treatment called ULSC to see if it can improve muscle strength and skin symptoms, and help reduce steroid use in people with dermatomyositis or polymyositis. It may be an option if standard treatments haven't worked well enough.
Gainesville, FloridaAges 18 years+
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,290 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.